ReviewACS omega2025
Exploring Recent Progress in First-Row Trimetallic Nanostructures and Their Derivatives for Electrocatalytic Water Splitting: A Comprehensive Review.
Review in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Nanostructured Catalysts for Electro- and Photocatalytic Energy Conversion: Design Strategies, Mechanistic Descriptors, and Practical Applications.Nanomaterials (Basel, Switzerland) · 2026Review
- The Hierarchical Trimetallic FeCoNi LTH/MnMoOACS applied materials & interfaces · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Present scientific efforts are heavily concentrated on enhancing energy storage and conversion technologies to reduce environmental degradation and tackle impending energy issues. Electrocatalytic water splitting emerges as a leading method for producing pure hydrogen without generating undesired byproducts, highlighting the need for robust, cost-effective, highly active, and earth-abundant electrocatalyst materials composed of non-noble metals that exhibit excellent stability and performance for both hydrogen evolution reaction (HER) and oxygen evolution reaction (OER) at low overpotentials and high efficiencies. In this context, the design and engineering of trimetallic nanostructured materials with diverse architectures emerge as a promising strategy for energy conversion electrocatalysis. These trimetallic nanostructures, particularly those incorporating first-row transition metals, exhibit distinctive physicochemical properties, heightened efficacy, and enhanced durability across diverse applications compared to mono- and bimetallic counterparts, driven by synergistic interactions among the trimetals. Moreover, the incorporation of additional metals into the secondary building units (SBUs) of frameworks represents an efficacious strategy for augmenting electrochemical performance and electrical conductivity, increasing active site exposure, enhanced charge capacity, and proficient charge transfer among distinct ions. In this review, fundamental concepts and key evaluation metrics for electrochemical water-splitting reactions are outlined. Subsequently, an overview of recent advancements in the synthesis, structural/chemical modifications, and utilization of first-row transition metals as multifunctional nanomaterials for overall water splitting is elucidated. Then, a comprehensive analysis is provided on various trimetallic catalyst categories based on first-row transition metals, encompassing alloys, oxides, hydroxides, nitrides/phosphides/sulfides, and composite structures, aiming to expand the understanding of trimetallic systems and delineate a roadmap for the integration of diverse trimetallic materials as advanced candidates in electrochemical energy storage and conversion technologies.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.